🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Atherosclerotic Cardiovascular Disease

ENhancing Exercise With LIGHT to Improve Functioning in PAD NCT06399900NA1 site📍 Chicago Northwestern University · Tests: Far red light therapy, Sham light therapy, Home-based walking exercise Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential NCT03291652n/a1 site📍 Hong Kong Chinese University of Hong Kong · Tests: DSA/3DRA Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis NCT07316452n/a1 site📍 Beijing Fu Wai Hospital, Beijing, China Twenty-four Hour Movement Behaviors and Atherosclerotic Risk NCT07774507n/a1 site📍 Presidente Prudente São Paulo State University BEETroot Juice to Reverse Functional Impairment in PAD NCT05624125NA4 sites📍 Chicago📍 Chicago📍 Minneapolis Northwestern University · Tests: Beetroot juice, Placebo Imaging and Physiologic Evaluation of Coronary Artery Disease NCT05124249n/a1 site📍 Gwangju Chonnam National University Hospital · Tests: Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment, PCI Peripheral Bypass Trial for Completion Control NCT06264843n/a1 site📍 San Francisco Medistim ASA · Tests: MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes Latvian Early Atherosclerosis Registry NCT06393894n/a1 site📍 Riga Pauls Stradins Clinical University Hospital · Tests: Near infrared spectroscopy, Genetic testing for LDLR, APOB, PCSK9 and LDLRAP1 mutations and niR-126, -145 and -155 expr… Carotid Atherosclerosis in Predicting Coronary Artery Disease NCT06253962n/a1 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: coronary agiongraphy Clinical Research Protocol of Ferumoxytol for Magnetic Resonance Enhancement Imaging in Patients With Atherosclerosis. NCT06551805n/a1 site📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: Safety assessment of Ferumoxytol., Assessment of the diagnostic value of Ferumoxytol for MR angiography. Durg Coated Balloon Angioplasty in Infrapopliteal Lesions NCT05620095n/a10 sites📍 Beijing📍 Wuhan📍 Suzhou Liyuan Hospital of Tongji Medical College, Huazhong Univers… · Tests: drug-coated balloon ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography NCT06676280Phase 432 sites📍 Anyang📍 Anyang📍 Bucheon-si Jung-min Ahn · Tests: Aspirin, High-intensity statin, Guideline-directed statin therapy Akershus Cardiac Examination (ACE) 5 Study NCT07301489NA1 site📍 Lørenskog University Hospital, Akershus · Tests: Lung Cancer Screening Plus Program, Standard of Care SMART Exercise for PAD NCT06032065Phase 33 sites📍 Chicago📍 Chicago📍 Minneapolis Northwestern University · Tests: Supervised Treadmill Exercise, Home-Based Exercise, Nitrate-rich beetroot Juice Determinants of Cardiorespiratory Fitness and Effects of HIIT in Patients With ANOCA Obstructive Coronary Artery Disease(ANOCA) NCT07182955NA1 site📍 Charlottesville University of Virginia · Tests: EXERCISE TRAINING WITH OR WITHOUT MEDICATION Exercise Testing in Peripheral Artery Disease Patients NCT03186391n/a1 site📍 Rennes Rennes University Hospital · Tests: Data collected A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease NCT07551492Phase 31 site📍 Beijing Fujian Shengdi Pharmaceutical Co., Ltd. · Tests: HRS9531, HRS9531 placebo Cardiometabolic Risk Factors Registry NCT04040777n/a1 site📍 Pilar Austral University, Argentina Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation NCT07556887NA10 sites📍 Arnhem📍 Nijmegen📍 Heerlen Maastricht University Medical Center · Tests: IMPROVE Risk Model PET/MR Multimodal Quantitative Analysis of CBF and CMRGlc in Cerebral Ischemia NCT07079345n/a1 site📍 Beijing Xuanwu Hospital, Beijing Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) NCT05485961Phase 2, Phase 3566 sites📍 Decatur📍 Huntsville📍 Montgomery CSL Behring · Tests: CSL300, Placebo Natural History of Coronary Atherosclerosis NCT06040073n/a1 site📍 Beijing China National Center for Cardiovascular Diseases Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions NCT06779630NA23 sites📍 Concord📍 Wichita📍 Boston Teleflex · Tests: Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis NCT07232069Phase 323 sites📍 Birmingham📍 Mobile📍 Los Angeles Duke University · Tests: Rosuvastatin 20 Mg Oral Tablet, Colchicine 0.5 MG Oral Tablet Once Daily, Placebo Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic Stroke NCT07026318NA1 site📍 Beijing Beijing Anzhen Hospital · Tests: Tirofiban, Placebo Translational Immunodiagnostics in Stroke (TrImS) NCT05300997n/a1 site📍 Hong Kong The University of Hong Kong · Tests: Biomarker blood draw and saliva collection PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis NCT06902740Phase 419 sites📍 Beijing📍 Beijing📍 Meizhou Peking Union Medical College Hospital · Tests: Recaticimab and Statin, Statin Digital Remote Management for Care and Continuous Optimization Versus Usual Care to Reduce Risk of Atherosclerotic Cardiovascular Diseases (DigiCare-preASCVD) NCT07332468NA5 sites📍 Beijing📍 Changchun📍 Dalian Beijing Anzhen Hospital · Tests: Digital Remote Management Group Vessel Recoil in Specific CLTI Populations NCT07465627n/a1 site📍 Graz Medical University of Graz · Tests: Vessel recoil measurement 15 minutes post final treatment (angiographically) Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression NCT06206369n/a6 sites📍 Helsinki📍 Hamburg📍 Amsterdam Amsterdam UMC, location VUmc · Tests: No intervention, retrospective study
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy